A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Public ClinicalTrials.gov record NCT01830543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the safety for 2 different rivaroxaban treatment strategies and one Vitamin K Antagonist (VKA) treatment strategy utilizing various combinations of dual antiplatelet therapy (DAPT) or low-dose aspirin (ASA) or clopidogrel (or prasugrel or ticagrelor).
Study identification
- NCT ID
- NCT01830543
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,124 participants
Conditions and interventions
Interventions
- rivaroxaban 2.5 mg Drug
- rivaroxaban 15 mg Drug
- rivaroxaban 10 mg Drug
- aspirin (ASA) Drug
- vitamin K antagonist (VKA) Drug
- clopidogrel Drug
- prasugrel Drug
- ticagrelor Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2013 (Actual)
- Primary completion
- Jul 28, 2016 (Actual)
- Completion
- Jul 28, 2016 (Actual)
- Last update posted
- Sep 19, 2017
2013 – 2016
United States locations
- U.S. sites
- 86
- U.S. states
- 32
- U.S. cities
- 86
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Los Alamitos | California | — | — |
| Not listed | Mission Viejo | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Francisco | California | — | — |
| Not listed | Stockton | California | — | — |
| Not listed | Thousand Oaks | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | Danbury | Connecticut | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Atlantis | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Port Charlotte | Florida | — | — |
| Not listed | Safety Harbor | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Hazel Crest | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Munster | Indiana | — | — |
| Not listed | Hammond | Louisiana | — | — |
| Not listed | Lake Charles | Louisiana | — | — |
| Not listed | Slidell | Louisiana | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Mount Clemens | Michigan | — | — |
| Not listed | Petoskey | Michigan | — | — |
| Not listed | Ypsilanti | Michigan | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Kalispell | Montana | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Hackensack | New Jersey | — | — |
| Not listed | Haddon Heights | New Jersey | — | — |
| Not listed | New Brunswick | New Jersey | — | — |
| Not listed | Newark | New Jersey | — | — |
| Not listed | Ridgewood | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Peekskill | New York | — | — |
| Not listed | Sanford | North Carolina | — | — |
| Not listed | Bartlesville | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Bend | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Abington | Pennsylvania | — | — |
| Not listed | Camp Hill | Pennsylvania | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Erie | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Sayre | Pennsylvania | — | — |
| Not listed | York | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Humble | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Layton | Utah | — | — |
| Not listed | Charlottesville | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Midlothian | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Bellevue | Washington | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
| Not listed | Weston | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 262 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01830543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2017 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01830543 live on ClinicalTrials.gov.